The promise of designer microbes inspires a $130M mega-round for Zymergen
These days, promising a tech revolution can be worth a fortune in venture backing. And that’s just what Zymergen just earned in its Series B …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
